Animal Model Core
动物模型核心
基本信息
- 批准号:10224227
- 负责人:
- 金额:$ 38.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary: Animal Models Core
Studies of antibiotic tolerance and of new therapies to treat antibiotic-resistant pathogens must, at some point,
be evaluated in mammalian models of infection. These pre-clinical assessments are a fundamental step to
determining whether treatments might be translated to human studies. Moreover, the complexities of the
mammalian immune response can be queried to gain insight into the basic pathobiology of infections and host
defenses. The Animal Models Core of the Center for Antimicrobial Resistance and Therapeutic Discovery
(CARTD) will enable pre-clinical studies in mice to facilitate rapid, high-quality data acquisition. The Core will
provide essential input, along with that from our biostatistics expert, to aid in experimental design that
enhances the robustness of the results. The Core Director will train the Junior Investigators and assist them in
obtaining the institutional approvals necessary to conduct animal experiments. The Core will maintain a
portfolio of techniques directly related to the experimental objectives of the research projects, as well as
expand the repertoire to diversify the research projects and to recruit investigators from beyond the CARTD.
The Core’s design includes blinding of treatment groups so that observers make unbiased assessments of the
animals throughout the experiment. The Core’s staff will conduct experiments in conjunction with the
laboratories of the research and pilot projects. Importantly, the Core will be responsible for managing the new
in vivo imaging system recently procured by our institution. This imaging system enhances the robustness and
reproducibility of the studies by longitudinal follow-up of individual animals while reducing the overall numbers
of animals that are required in any given experiment. The Animal Models Core’s functions are defined by the
following specific aims: 1. To provide consultation and assistance in planning experimental design, strain
selection, and outcomes analysis. 2. To conduct infection and treatment experiments in collaboration with
investigators from the Junior Investigator and Pilot Project research programs, as well as outside researchers.
3. To supervise, schedule, maintain, and operate the PerkinElmer IVIS Lumina III in vivo imaging system.
项目摘要:动物模型核心
对治疗抗生素耐药病原体的抗生素耐受性和新疗法的研究必须在某个时候
在感染的哺乳动物模型中进行评估。这些临床前评估是
确定是否可以将治疗转化为人类研究。而且,
可以查询哺乳动物免疫反应以深入了解感染和宿主的基本病理学
防御。动物模型抗菌耐药性和治疗发现中心的核心
(CARTD)将使小鼠进行临床前研究,以促进快速,高质量的数据获取。核心意愿
提供基本的输入以及我们的生物统计学专家,以帮助实验设计
增强结果的鲁棒性。核心主任将培训初级调查员并协助他们
获得进行动物实验所需的机构批准。核心将保持
技术组合与研究项目的实验目标直接相关,以及
扩展曲目,以使研究项目多样化,并从CARTD以外招募研究人员。
核心的设计包括对治疗组的盲目,以便观察者对
整个实验中的动物。核心人员将与
研究和试点项目的实验室。重要的是,核心将负责管理新的
我们机构最近采购的体内成像系统。这个成像系统增强了鲁棒性和
研究通过纵向随访的单个动物的可重复性,同时减少总数
在任何给定实验中都需要的动物。动物模型核心的功能由
以下具体目的:1。为计划实验设计提供咨询和帮助
选择和结果分析。 2。与
初级研究员和试点项目研究计划以及外部研究人员的研究人员。
3。监督,安排,维护和操作Perkinelmer Ivis Lumina III体内成像系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Gerard J Nau的其他基金
Pulmonary infection by aerosol: pathogenesis and intervention
气溶胶肺部感染:发病机制和干预
- 批准号:83325298332529
- 财政年份:2011
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Pulmonary infection by aerosol: pathogenesis and intervention
气溶胶肺部感染:发病机制和干预
- 批准号:76699357669935
- 财政年份:2009
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Novel Selectable Markers for F. tularensis
土拉弗朗西斯的新型可选择标记
- 批准号:72845587284558
- 财政年份:2007
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Novel Selectable Markers for F. tularensis
土拉弗朗西斯的新型可选择标记
- 批准号:74580287458028
- 财政年份:2007
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Host Defenses and Susceptibility to Tuberculosis
宿主防御和结核病易感性
- 批准号:72299877229987
- 财政年份:2006
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Host Defenses and Susceptibility to Tuberculosis
宿主防御和结核病易感性
- 批准号:70360867036086
- 财政年份:2006
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
MOLECULAR ANALYSIS OF MYCOBACTERIAL GENE EXPRESSION
分枝杆菌基因表达的分子分析
- 批准号:20575792057579
- 财政年份:1995
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
MOLECULAR ANALYSIS OF MYCOBACTERIAL GENE EXPRESSION
分枝杆菌基因表达的分子分析
- 批准号:26713722671372
- 财政年份:1995
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
MOLECULAR ANALYSIS OF MYCOBACTERIAL GENE EXPRESSION
分枝杆菌基因表达的分子分析
- 批准号:25171242517124
- 财政年份:1995
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
相似国自然基金
构建环状RNA调控肝癌干细胞干性维持的实验动物模型及机制研究
- 批准号:32070533
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
大鼠创伤性颞下颌关节强直实验动物模型的构建及发生机制研究
- 批准号:81970954
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
髌骨脱位后股骨滑车发育不良的实验动物模型研究
- 批准号:81873983
- 批准年份:2018
- 资助金额:75.0 万元
- 项目类别:面上项目
舒张性心衰(HFpEF)的动物模型:机理研究和实验治疗
- 批准号:81770265
- 批准年份:2017
- 资助金额:80.0 万元
- 项目类别:面上项目
基于神经中央软骨生长调控的早发性脊柱侧弯矫正模式的动物实验研究
- 批准号:81772422
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Swine Somatic Cell Gene Editing Testing Center
猪体细胞基因编辑检测中心
- 批准号:1077379610773796
- 财政年份:2023
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Soft wireless multimodal cardiac implantable devices for long-term investigating heart failure pathogenesis
用于长期研究心力衰竭发病机制的软无线多模式心脏植入装置
- 批准号:1073539510735395
- 财政年份:2023
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
- 批准号:1071220210712202
- 财政年份:2023
- 资助金额:$ 38.52万$ 38.52万
- 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:1064251910642519
- 财政年份:2023
- 资助金额:$ 38.52万$ 38.52万
- 项目类别: